Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria

Completed

Conditions studied: Porphyrias

In brief

This is an observational study collecting patient/caregiver reports on suspected medication/drug-induced acute porphyria attacks, as well as safe use of drugs previously labeled "unsafe" or with unknown risk. Participants will be recruited through the RDCRN Contact Registry for the Porphyrias Consortium. The study will be advertised on the Consortium website and through the American Porphyria Foundation's social media network.

Key facts

Study ID

NCT03906214

Run by

University of South Florida

People needed

60

Starts

2019-04-03

Expected to finish

2019-09-13

Last updated by the study team

2019-10-16

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Able to read and write in English
• Enrolled in the RDCRN PC Contact Registry
• Self-reported patient or caregiver of patient with acute porphyria
• There are no restrictions on age, sex or ethnicity. However, the following criteria will be applied to those reports that are considered evaluable (analyzed and scored):
• Medication name must be specified
• The data elements required in the scoring system must be complete

You may not qualify if…

• Unable to provide informed consent and complete forms

Where it is running

• University of South Florida Data Management Coordinating Center — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.